世界の放射性医薬品市場予測2023-2029:アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他

【英語タイトル】Radiopharmaceutical Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23FB2506)・商品コード:MMG23FB2506
・発行会社(調査会社):Market Monitor Global
・発行日:2023年2月
・ページ数:115
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の放射性医薬品市場規模と予測を収録しています。・世界の放射性医薬品市場:売上、2018年-2023年、2024年-2029年
・世界の放射性医薬品市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の放射性医薬品市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「アクチニウム-225」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

放射性医薬品のグローバル主要企業は、Bracco Imaging、Bayer、Mallinckrodt、Nordion、Triad Isotopes、Lantheus、IBA Group、GE Healthcare、China Isotope & Radiation、Jubilant Pharma、Eli Lilly、Advanced Accelerator Applications、SIEMENS、Dongcheng、Navideaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、放射性医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の放射性医薬品市場:タイプ別、2018年-2023年、2024年-2029年
世界の放射性医薬品市場:タイプ別市場シェア、2022年
・アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他

世界の放射性医薬品市場:用途別、2018年-2023年、2024年-2029年
世界の放射性医薬品市場:用途別市場シェア、2022年
・腫瘍学、循環器内科、その他

世界の放射性医薬品市場:地域・国別、2018年-2023年、2024年-2029年
世界の放射性医薬品市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における放射性医薬品のグローバル売上、2018年-2023年
・主要企業における放射性医薬品のグローバル売上シェア、2022年
・主要企業における放射性医薬品のグローバル販売量、2018年-2023年
・主要企業における放射性医薬品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Bracco Imaging、Bayer、Mallinckrodt、Nordion、Triad Isotopes、Lantheus、IBA Group、GE Healthcare、China Isotope & Radiation、Jubilant Pharma、Eli Lilly、Advanced Accelerator Applications、SIEMENS、Dongcheng、Navidea

*************************************************************

・調査・分析レポートの概要
放射性医薬品市場の定義
市場セグメント
世界の放射性医薬品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の放射性医薬品市場規模
世界の放射性医薬品市場規模:2022年 VS 2029年
世界の放射性医薬品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの放射性医薬品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の放射性医薬品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他
放射性医薬品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:腫瘍学、循環器内科、その他
放射性医薬品の用途別グローバル売上・予測

・地域別市場分析
地域別放射性医薬品市場規模 2022年と2029年
地域別放射性医薬品売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Bracco Imaging、Bayer、Mallinckrodt、Nordion、Triad Isotopes、Lantheus、IBA Group、GE Healthcare、China Isotope & Radiation、Jubilant Pharma、Eli Lilly、Advanced Accelerator Applications、SIEMENS、Dongcheng、Navidea

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Radiopharmaceutical Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radiopharmaceutical Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radiopharmaceutical Overall Market Size
2.1 Global Radiopharmaceutical Market Size: 2022 VS 2029
2.2 Global Radiopharmaceutical Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Radiopharmaceutical Sales: 2018-2029
3 Company Landscape
3.1 Top Radiopharmaceutical Players in Global Market
3.2 Top Global Radiopharmaceutical Companies Ranked by Revenue
3.3 Global Radiopharmaceutical Revenue by Companies
3.4 Global Radiopharmaceutical Sales by Companies
3.5 Global Radiopharmaceutical Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Radiopharmaceutical Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Radiopharmaceutical Product Type
3.8 Tier 1, Tier 2 and Tier 3 Radiopharmaceutical Players in Global Market
3.8.1 List of Global Tier 1 Radiopharmaceutical Companies
3.8.2 List of Global Tier 2 and Tier 3 Radiopharmaceutical Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Radiopharmaceutical Market Size Markets, 2022 & 2029
4.1.2 Actinium-225
4.1.3 Lutetium-177
4.1.4 Radium-223
4.1.5 Holmium-166
4.1.6 Other
4.2 By Type – Global Radiopharmaceutical Revenue & Forecasts
4.2.1 By Type – Global Radiopharmaceutical Revenue, 2018-2023
4.2.2 By Type – Global Radiopharmaceutical Revenue, 2024-2029
4.2.3 By Type – Global Radiopharmaceutical Revenue Market Share, 2018-2029
4.3 By Type – Global Radiopharmaceutical Sales & Forecasts
4.3.1 By Type – Global Radiopharmaceutical Sales, 2018-2023
4.3.2 By Type – Global Radiopharmaceutical Sales, 2024-2029
4.3.3 By Type – Global Radiopharmaceutical Sales Market Share, 2018-2029
4.4 By Type – Global Radiopharmaceutical Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Radiopharmaceutical Market Size, 2022 & 2029
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Other
5.2 By Application – Global Radiopharmaceutical Revenue & Forecasts
5.2.1 By Application – Global Radiopharmaceutical Revenue, 2018-2023
5.2.2 By Application – Global Radiopharmaceutical Revenue, 2024-2029
5.2.3 By Application – Global Radiopharmaceutical Revenue Market Share, 2018-2029
5.3 By Application – Global Radiopharmaceutical Sales & Forecasts
5.3.1 By Application – Global Radiopharmaceutical Sales, 2018-2023
5.3.2 By Application – Global Radiopharmaceutical Sales, 2024-2029
5.3.3 By Application – Global Radiopharmaceutical Sales Market Share, 2018-2029
5.4 By Application – Global Radiopharmaceutical Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Radiopharmaceutical Market Size, 2022 & 2029
6.2 By Region – Global Radiopharmaceutical Revenue & Forecasts
6.2.1 By Region – Global Radiopharmaceutical Revenue, 2018-2023
6.2.2 By Region – Global Radiopharmaceutical Revenue, 2024-2029
6.2.3 By Region – Global Radiopharmaceutical Revenue Market Share, 2018-2029
6.3 By Region – Global Radiopharmaceutical Sales & Forecasts
6.3.1 By Region – Global Radiopharmaceutical Sales, 2018-2023
6.3.2 By Region – Global Radiopharmaceutical Sales, 2024-2029
6.3.3 By Region – Global Radiopharmaceutical Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Radiopharmaceutical Revenue, 2018-2029
6.4.2 By Country – North America Radiopharmaceutical Sales, 2018-2029
6.4.3 US Radiopharmaceutical Market Size, 2018-2029
6.4.4 Canada Radiopharmaceutical Market Size, 2018-2029
6.4.5 Mexico Radiopharmaceutical Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Radiopharmaceutical Revenue, 2018-2029
6.5.2 By Country – Europe Radiopharmaceutical Sales, 2018-2029
6.5.3 Germany Radiopharmaceutical Market Size, 2018-2029
6.5.4 France Radiopharmaceutical Market Size, 2018-2029
6.5.5 U.K. Radiopharmaceutical Market Size, 2018-2029
6.5.6 Italy Radiopharmaceutical Market Size, 2018-2029
6.5.7 Russia Radiopharmaceutical Market Size, 2018-2029
6.5.8 Nordic Countries Radiopharmaceutical Market Size, 2018-2029
6.5.9 Benelux Radiopharmaceutical Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Radiopharmaceutical Revenue, 2018-2029
6.6.2 By Region – Asia Radiopharmaceutical Sales, 2018-2029
6.6.3 China Radiopharmaceutical Market Size, 2018-2029
6.6.4 Japan Radiopharmaceutical Market Size, 2018-2029
6.6.5 South Korea Radiopharmaceutical Market Size, 2018-2029
6.6.6 Southeast Asia Radiopharmaceutical Market Size, 2018-2029
6.6.7 India Radiopharmaceutical Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Radiopharmaceutical Revenue, 2018-2029
6.7.2 By Country – South America Radiopharmaceutical Sales, 2018-2029
6.7.3 Brazil Radiopharmaceutical Market Size, 2018-2029
6.7.4 Argentina Radiopharmaceutical Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Radiopharmaceutical Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Radiopharmaceutical Sales, 2018-2029
6.8.3 Turkey Radiopharmaceutical Market Size, 2018-2029
6.8.4 Israel Radiopharmaceutical Market Size, 2018-2029
6.8.5 Saudi Arabia Radiopharmaceutical Market Size, 2018-2029
6.8.6 UAE Radiopharmaceutical Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bracco Imaging
7.1.1 Bracco Imaging Company Summary
7.1.2 Bracco Imaging Business Overview
7.1.3 Bracco Imaging Radiopharmaceutical Major Product Offerings
7.1.4 Bracco Imaging Radiopharmaceutical Sales and Revenue in Global (2018-2023)
7.1.5 Bracco Imaging Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Radiopharmaceutical Major Product Offerings
7.2.4 Bayer Radiopharmaceutical Sales and Revenue in Global (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 Mallinckrodt
7.3.1 Mallinckrodt Company Summary
7.3.2 Mallinckrodt Business Overview
7.3.3 Mallinckrodt Radiopharmaceutical Major Product Offerings
7.3.4 Mallinckrodt Radiopharmaceutical Sales and Revenue in Global (2018-2023)
7.3.5 Mallinckrodt Key News & Latest Developments
7.4 Nordion
7.4.1 Nordion Company Summary
7.4.2 Nordion Business Overview
7.4.3 Nordion Radiopharmaceutical Major Product Offerings
7.4.4 Nordion Radiopharmaceutical Sales and Revenue in Global (2018-2023)
7.4.5 Nordion Key News & Latest Developments
7.5 Triad Isotopes
7.5.1 Triad Isotopes Company Summary
7.5.2 Triad Isotopes Business Overview
7.5.3 Triad Isotopes Radiopharmaceutical Major Product Offerings
7.5.4 Triad Isotopes Radiopharmaceutical Sales and Revenue in Global (2018-2023)
7.5.5 Triad Isotopes Key News & Latest Developments
7.6 Lantheus
7.6.1 Lantheus Company Summary
7.6.2 Lantheus Business Overview
7.6.3 Lantheus Radiopharmaceutical Major Product Offerings
7.6.4 Lantheus Radiopharmaceutical Sales and Revenue in Global (2018-2023)
7.6.5 Lantheus Key News & Latest Developments
7.7 IBA Group
7.7.1 IBA Group Company Summary
7.7.2 IBA Group Business Overview
7.7.3 IBA Group Radiopharmaceutical Major Product Offerings
7.7.4 IBA Group Radiopharmaceutical Sales and Revenue in Global (2018-2023)
7.7.5 IBA Group Key News & Latest Developments
7.8 GE Healthcare
7.8.1 GE Healthcare Company Summary
7.8.2 GE Healthcare Business Overview
7.8.3 GE Healthcare Radiopharmaceutical Major Product Offerings
7.8.4 GE Healthcare Radiopharmaceutical Sales and Revenue in Global (2018-2023)
7.8.5 GE Healthcare Key News & Latest Developments
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Company Summary
7.9.2 China Isotope & Radiation Business Overview
7.9.3 China Isotope & Radiation Radiopharmaceutical Major Product Offerings
7.9.4 China Isotope & Radiation Radiopharmaceutical Sales and Revenue in Global (2018-2023)
7.9.5 China Isotope & Radiation Key News & Latest Developments
7.10 Jubilant Pharma
7.10.1 Jubilant Pharma Company Summary
7.10.2 Jubilant Pharma Business Overview
7.10.3 Jubilant Pharma Radiopharmaceutical Major Product Offerings
7.10.4 Jubilant Pharma Radiopharmaceutical Sales and Revenue in Global (2018-2023)
7.10.5 Jubilant Pharma Key News & Latest Developments
7.11 Eli Lilly
7.11.1 Eli Lilly Company Summary
7.11.2 Eli Lilly Radiopharmaceutical Business Overview
7.11.3 Eli Lilly Radiopharmaceutical Major Product Offerings
7.11.4 Eli Lilly Radiopharmaceutical Sales and Revenue in Global (2018-2023)
7.11.5 Eli Lilly Key News & Latest Developments
7.12 Advanced Accelerator Applications
7.12.1 Advanced Accelerator Applications Company Summary
7.12.2 Advanced Accelerator Applications Radiopharmaceutical Business Overview
7.12.3 Advanced Accelerator Applications Radiopharmaceutical Major Product Offerings
7.12.4 Advanced Accelerator Applications Radiopharmaceutical Sales and Revenue in Global (2018-2023)
7.12.5 Advanced Accelerator Applications Key News & Latest Developments
7.13 SIEMENS
7.13.1 SIEMENS Company Summary
7.13.2 SIEMENS Radiopharmaceutical Business Overview
7.13.3 SIEMENS Radiopharmaceutical Major Product Offerings
7.13.4 SIEMENS Radiopharmaceutical Sales and Revenue in Global (2018-2023)
7.13.5 SIEMENS Key News & Latest Developments
7.14 Dongcheng
7.14.1 Dongcheng Company Summary
7.14.2 Dongcheng Business Overview
7.14.3 Dongcheng Radiopharmaceutical Major Product Offerings
7.14.4 Dongcheng Radiopharmaceutical Sales and Revenue in Global (2018-2023)
7.14.5 Dongcheng Key News & Latest Developments
7.15 Navidea
7.15.1 Navidea Company Summary
7.15.2 Navidea Business Overview
7.15.3 Navidea Radiopharmaceutical Major Product Offerings
7.15.4 Navidea Radiopharmaceutical Sales and Revenue in Global (2018-2023)
7.15.5 Navidea Key News & Latest Developments
8 Global Radiopharmaceutical Production Capacity, Analysis
8.1 Global Radiopharmaceutical Production Capacity, 2018-2029
8.2 Radiopharmaceutical Production Capacity of Key Manufacturers in Global Market
8.3 Global Radiopharmaceutical Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Radiopharmaceutical Supply Chain Analysis
10.1 Radiopharmaceutical Industry Value Chain
10.2 Radiopharmaceutical Upstream Market
10.3 Radiopharmaceutical Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Radiopharmaceutical Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Radiopharmaceutical in Global Market
Table 2. Top Radiopharmaceutical Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Radiopharmaceutical Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Radiopharmaceutical Revenue Share by Companies, 2018-2023
Table 5. Global Radiopharmaceutical Sales by Companies, (M Doses), 2018-2023
Table 6. Global Radiopharmaceutical Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Radiopharmaceutical Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Radiopharmaceutical Product Type
Table 9. List of Global Tier 1 Radiopharmaceutical Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Radiopharmaceutical Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Radiopharmaceutical Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Radiopharmaceutical Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Radiopharmaceutical Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Radiopharmaceutical Sales (M Doses), 2018-2023
Table 15. By Type - Global Radiopharmaceutical Sales (M Doses), 2024-2029
Table 16. By Application – Global Radiopharmaceutical Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Radiopharmaceutical Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Radiopharmaceutical Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Radiopharmaceutical Sales (M Doses), 2018-2023
Table 20. By Application - Global Radiopharmaceutical Sales (M Doses), 2024-2029
Table 21. By Region – Global Radiopharmaceutical Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Radiopharmaceutical Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Radiopharmaceutical Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Radiopharmaceutical Sales (M Doses), 2018-2023
Table 25. By Region - Global Radiopharmaceutical Sales (M Doses), 2024-2029
Table 26. By Country - North America Radiopharmaceutical Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Radiopharmaceutical Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Radiopharmaceutical Sales, (M Doses), 2018-2023
Table 29. By Country - North America Radiopharmaceutical Sales, (M Doses), 2024-2029
Table 30. By Country - Europe Radiopharmaceutical Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Radiopharmaceutical Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Radiopharmaceutical Sales, (M Doses), 2018-2023
Table 33. By Country - Europe Radiopharmaceutical Sales, (M Doses), 2024-2029
Table 34. By Region - Asia Radiopharmaceutical Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Radiopharmaceutical Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Radiopharmaceutical Sales, (M Doses), 2018-2023
Table 37. By Region - Asia Radiopharmaceutical Sales, (M Doses), 2024-2029
Table 38. By Country - South America Radiopharmaceutical Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Radiopharmaceutical Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Radiopharmaceutical Sales, (M Doses), 2018-2023
Table 41. By Country - South America Radiopharmaceutical Sales, (M Doses), 2024-2029
Table 42. By Country - Middle East & Africa Radiopharmaceutical Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Radiopharmaceutical Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Radiopharmaceutical Sales, (M Doses), 2018-2023
Table 45. By Country - Middle East & Africa Radiopharmaceutical Sales, (M Doses), 2024-2029
Table 46. Bracco Imaging Company Summary
Table 47. Bracco Imaging Radiopharmaceutical Product Offerings
Table 48. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. Bracco Imaging Key News & Latest Developments
Table 50. Bayer Company Summary
Table 51. Bayer Radiopharmaceutical Product Offerings
Table 52. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. Bayer Key News & Latest Developments
Table 54. Mallinckrodt Company Summary
Table 55. Mallinckrodt Radiopharmaceutical Product Offerings
Table 56. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. Mallinckrodt Key News & Latest Developments
Table 58. Nordion Company Summary
Table 59. Nordion Radiopharmaceutical Product Offerings
Table 60. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. Nordion Key News & Latest Developments
Table 62. Triad Isotopes Company Summary
Table 63. Triad Isotopes Radiopharmaceutical Product Offerings
Table 64. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. Triad Isotopes Key News & Latest Developments
Table 66. Lantheus Company Summary
Table 67. Lantheus Radiopharmaceutical Product Offerings
Table 68. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. Lantheus Key News & Latest Developments
Table 70. IBA Group Company Summary
Table 71. IBA Group Radiopharmaceutical Product Offerings
Table 72. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. IBA Group Key News & Latest Developments
Table 74. GE Healthcare Company Summary
Table 75. GE Healthcare Radiopharmaceutical Product Offerings
Table 76. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 77. GE Healthcare Key News & Latest Developments
Table 78. China Isotope & Radiation Company Summary
Table 79. China Isotope & Radiation Radiopharmaceutical Product Offerings
Table 80. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 81. China Isotope & Radiation Key News & Latest Developments
Table 82. Jubilant Pharma Company Summary
Table 83. Jubilant Pharma Radiopharmaceutical Product Offerings
Table 84. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 85. Jubilant Pharma Key News & Latest Developments
Table 86. Eli Lilly Company Summary
Table 87. Eli Lilly Radiopharmaceutical Product Offerings
Table 88. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 89. Eli Lilly Key News & Latest Developments
Table 90. Advanced Accelerator Applications Company Summary
Table 91. Advanced Accelerator Applications Radiopharmaceutical Product Offerings
Table 92. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 93. Advanced Accelerator Applications Key News & Latest Developments
Table 94. SIEMENS Company Summary
Table 95. SIEMENS Radiopharmaceutical Product Offerings
Table 96. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 97. SIEMENS Key News & Latest Developments
Table 98. Dongcheng Company Summary
Table 99. Dongcheng Radiopharmaceutical Product Offerings
Table 100. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 101. Dongcheng Key News & Latest Developments
Table 102. Navidea Company Summary
Table 103. Navidea Radiopharmaceutical Product Offerings
Table 104. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 105. Navidea Key News & Latest Developments
Table 106. Radiopharmaceutical Production Capacity (M Doses) of Key Manufacturers in Global Market, 2021-2023 (M Doses)
Table 107. Global Radiopharmaceutical Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Radiopharmaceutical Production by Region, 2018-2023 (M Doses)
Table 109. Global Radiopharmaceutical Production by Region, 2024-2029 (M Doses)
Table 110. Radiopharmaceutical Market Opportunities & Trends in Global Market
Table 111. Radiopharmaceutical Market Drivers in Global Market
Table 112. Radiopharmaceutical Market Restraints in Global Market
Table 113. Radiopharmaceutical Raw Materials
Table 114. Radiopharmaceutical Raw Materials Suppliers in Global Market
Table 115. Typical Radiopharmaceutical Downstream
Table 116. Radiopharmaceutical Downstream Clients in Global Market
Table 117. Radiopharmaceutical Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Radiopharmaceutical Segment by Type in 2022
Figure 2. Radiopharmaceutical Segment by Application in 2022
Figure 3. Global Radiopharmaceutical Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Radiopharmaceutical Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Radiopharmaceutical Revenue, 2018-2029 (US$, Mn)
Figure 7. Radiopharmaceutical Sales in Global Market: 2018-2029 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Radiopharmaceutical Revenue in 2022
Figure 9. By Type - Global Radiopharmaceutical Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Radiopharmaceutical Revenue Market Share, 2018-2029
Figure 11. By Type - Global Radiopharmaceutical Sales Market Share, 2018-2029
Figure 12. By Type - Global Radiopharmaceutical Price (USD/Dose), 2018-2029
Figure 13. By Application - Global Radiopharmaceutical Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Radiopharmaceutical Revenue Market Share, 2018-2029
Figure 15. By Application - Global Radiopharmaceutical Sales Market Share, 2018-2029
Figure 16. By Application - Global Radiopharmaceutical Price (USD/Dose), 2018-2029
Figure 17. By Region - Global Radiopharmaceutical Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Radiopharmaceutical Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Radiopharmaceutical Revenue Market Share, 2018-2029
Figure 20. By Region - Global Radiopharmaceutical Sales Market Share, 2018-2029
Figure 21. By Country - North America Radiopharmaceutical Revenue Market Share, 2018-2029
Figure 22. By Country - North America Radiopharmaceutical Sales Market Share, 2018-2029
Figure 23. US Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Radiopharmaceutical Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Radiopharmaceutical Sales Market Share, 2018-2029
Figure 28. Germany Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 29. France Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Radiopharmaceutical Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Radiopharmaceutical Sales Market Share, 2018-2029
Figure 37. China Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 41. India Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Radiopharmaceutical Revenue Market Share, 2018-2029
Figure 43. By Country - South America Radiopharmaceutical Sales Market Share, 2018-2029
Figure 44. Brazil Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Radiopharmaceutical Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Radiopharmaceutical Sales Market Share, 2018-2029
Figure 48. Turkey Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Radiopharmaceutical Revenue, (US$, Mn), 2018-2029
Figure 52. Global Radiopharmaceutical Production Capacity (M Doses), 2018-2029
Figure 53. The Percentage of Production Radiopharmaceutical by Region, 2022 VS 2029
Figure 54. Radiopharmaceutical Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の放射性医薬品市場予測2023-2029:アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他] (コード:MMG23FB2506)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の放射性医薬品市場予測2023-2029:アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆